French drug major Sanofi (Euronext: SAN) has replaced its North American chief Anne Whitaker with Jez Moulding, who will be head of the region’s pharma business following a senior management role in Japan and Asia Pacific. Mr Moulding will oversee commercial operations across the business.
He has previously served in Sanofi positions across the UK, Europe, South Africa, Korea, Australia and Japan.
Peter Guenter, executive vice president of global commercial operations, said: "Jez brings 20 years of valuable experience to North America Pharmaceuticals that he gained within complex and dynamic markets. This experience will serve him well in the evolving U.S. and Canadian healthcare environments."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze